Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer, Corning to Develop Label-Free Screening Tech

NEW YORK (GenomeWeb News) – PerkinElmer and Corning will collaborate to develop label-free detection technologies for the drug discovery market, Corning said today.

Under the agreement, the companies will combine Corning's optical label-free detection technology with PerkinElmer's multi-label detection systems to offer next-generation drug discovery platforms.

The agreement will combine the Corning Epic system with PerkinElmer's technologies to "provide drug discovery and life science researchers with deeper insights into biomolecular and cellular interactions," PerkinElmer Bio-discovery President Richard Eglen said in a statement.

Financial and other terms of the pact were not disclosed.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.